We are live on
!
Find out more
CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
This Quarter
Est. Return
-2.78%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$550M
AUM Growth
-$25.8M
(-4.5%)
Cap. Flow
-$3.46M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
683
New
116
Increased
168
Reduced
251
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.19M |
| 2 |
Intel
INTC
|
+$2.13M |
| 3 |
HCA Healthcare
HCA
|
+$2.1M |
| 4 |
AT&T
T
|
+$2.05M |
| 5 |
Target
TGT
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$2.95M |
| 2 |
Marathon Petroleum
MPC
|
+$2.83M |
| 3 |
Occidental Petroleum
OXY
|
+$2.71M |
| 4 |
Dow Inc
DOW
|
+$2.68M |
| 5 |
Citizens Financial Group
CFG
|
+$2.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.39% |
| 2 | Financials | 16.43% |
| 3 | Healthcare | 14.65% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
ALX Oncology
ALXO
$285M
| $168K | 0.03% |
35,071
+2,288
| +7% | +$12.4K |
|
502
Cullinan Oncology
CGEM
$1.18B
| $168K | 0.03% |
18,591
-204
| -1% | -$2.13K |
|
503
MacroGenics
MGNX
$259M
| $165K | 0.03% |
35,343
-390
| -1% | -$1.94K |
|
504
Zymeworks
ZYME
$1.71B
| $163K | 0.03% |
+25,755
| New | +$190K |
|
|
LENZ
505
LENZ Therapeutics
LENZ
$168M
| $163K | 0.03% |
9,362
-128
| -1% | -$2.23K |
|
|
IMA
506
ImageneBio Inc
IMA
$64.9M
| $161K | 0.03% |
3,104
-92
| -3% | -$5.54K |
|
507
Alector
ALEC
$189M
| $159K | 0.03% |
24,532
+322
| +1% | +$2.08K |
|
508
Nuvation Bio
NUVB
$2.32B
| $158K | 0.03% |
118,057
-1,228
| -1% | -$2.04K |
|
509
Enanta Pharmaceuticals
ENTA
$402M
| $157K | 0.03% |
+14,015
| New | +$226K |
|
510
MeiraGTx Holdings
MGTX
$1.21B
| $156K | 0.03% |
31,866
-337
| -1% | -$2.05K |
|
|
LONA
511
LeonaBio Inc
LONA
$70.5M
| $152K | 0.03% |
7,539
+14
| +0.2% | +$359 |
|
|
LIAN
512
DELISTED
LianBio American Depositary Shares
LIAN
| $151K | 0.03% |
101,039
-1,198
| -1% | -$2.28K |
|
513
Kymera Therapeutics
KYMR
$9.03B
| $149K | 0.03% |
+10,753
| New | +$216K |
|
514
Edgewise Therapeutics
EWTX
$4.84B
| $149K | 0.03% |
26,023
+916
| +4% | +$6.23K |
|
515
Pyxis Oncology
PYXS
$243M
| $149K | 0.03% |
74,903
-1,002
| -1% | -$2.32K |
|
516
Nurix Therapeutics
NRIX
$2.69B
| $145K | 0.03% |
18,511
-245
| -1% | -$2.24K |
|
|
ITOS
517
DELISTED
iTeos Therapeutics
ITOS
| $144K | 0.03% |
13,188
+631
| +5% | +$8.07K |
|
518
Iovance Biotherapeutics
IOVA
$2.9B
| $144K | 0.03% |
31,714
-450
| -1% | -$2.94K |
|
|
GBIO
519
DELISTED
Generation Bio
GBIO
| $143K | 0.03% |
3,768
-38
| -1% | -$1.8K |
|
520
Lyell Immunopharma
LYEL
$351M
| $143K | 0.03% |
+4,856
| New | +$231K |
|
521
Vanda Pharmaceuticals
VNDA
$304M
| $142K | 0.03% |
32,895
-108
| -0.3% | -$600 |
|
|
KLRS
522
Kalaris Therapeutics
KLRS
$93.7M
| $141K | 0.03% |
2,846
-37
| -1% | -$2.52K |
|
523
Monte Rosa Therapeutics
GLUE
$1.35B
| $133K | 0.02% |
27,844
-348
| -1% | -$2.24K |
|
524
Cue Biopharma
CUE
$110M
| $133K | 0.02% |
1,930
-25
| -1% | -$2.44K |
|
|
GRTS
525
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $132K | 0.02% |
76,811
-1,037
| -1% | -$1.84K |
|
Similar funds
NWM
EECFX
PSB
HIA
NMG
EECFX
BC
EFA
Cornercap Investment Counsel's Q3 2023 Portfolio in Review
As of Q3 2023, Cornercap Investment Counsel held 683 positions worth $550M, down 4.5% from $575M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Cornercap Investment Counsel's Q3 2023 filing shows 116 new, 168 increased, 251 reduced and 120 closed positions. Its largest new stake was Clorox: 14,394 shares worth $1.89M. The largest sale was Wabtec, an estimated $2.95M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
- Cornercap Investment Counsel's largest Q3 2023 buy was Clorox: 14,394 shares worth $1.89M.
- Cornercap Investment Counsel added most to Kraft Heinz in Q3 2023, an estimated $1.84M increase.
- Cornercap Investment Counsel's biggest Q3 2023 reduction was Automatic Data Processing, cutting an estimated $2.24M.
- Cornercap Investment Counsel fully exited Wabtec in Q3 2023, selling an estimated $2.95M.
- Cornercap Investment Counsel's ten largest holdings make up 8.9% of its $550M portfolio in Q3 2023.
- Cornercap Investment Counsel opened 116 new positions and closed 120 in Q3 2023.
- Cornercap Investment Counsel's portfolio value fell 4.5% quarter-over-quarter to $550M.
Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.